IL33 and osteoporosis: Furthermore, although serum IL-33 levels are lower in menopausal women with osteoporosis than those with normal BMD, the likely protective effect of IL-33 on the bone tends to disappear as the disease progresses, probably due to the interference of other osteoclastogenic cytokines.